GFAP and Alzheimer disease: However, when we measured the percentage of IBA1- and GFAP-positive staining surrounding the three previously classified plaque types, we detected significantly greater levels of IBA1 around the filamentous plaques in AsymAD MFGs than in AD MFGs (Fig. 3c), whereas GFAP levels were decreased in intermediate plaques (Fig. 3f).